Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

OpenAI CEO Sam Altman's decision to join President Trump's "Stargate" AI initiative marks a stark reversal for the tech CEO, ...

Kevin Zhou's Sam Altman, published in November 2024, is a detailed portrait of the AI entrepreneur, from his early days as a ... ended up taking part. The biography offers contradictory views ...

OpenAI Chief Executive Officer Sam Altman welcomed the debut of DeepSeek’s R1 model in a post on X late on Monday.

OpenAI chief executive Sam Altman, who provided the initial $180mn ... which will be tested in an early stage study in Australia this year. It is also working on drugs for rejuvenating blood ...

The dispute between arguably the two biggest names in generative artificial intelligence—billionaires Sam Altman and Elon Musk—erupted this week after President Donald Trump announced a $500 ...

OpenAI chief Sam Altman has ... It's not the first time Altman and Musk have publicly sparred with each other online. The pair have a history that goes back to OpenAI's early days.

The race to increase human life span through ... that’s set to enter an early-stage trial in Australia this year. Some of the investment will come from OpenAI CEO Sam Altman, who also provided ...